ARCHIVES

Phase III Data of Antibody-Drug Conjugate Shows PFS Increase in HER2+ Disease

This article is from The Cancer Letter archive.

Vol. 35 No. 6 | June 29, 2012

Download PDF Visit The Full Archive

Related Articles

NIH Study Confirms Male Risk Factors For Breast Cancer

February 28, 2014

NCI Grant Funding: “Zone of Likelihood” Moves From 7th to 9th Percentile

November 30, 2012

Vanderbilt, Jonsson Centers Win NCI SPORE Grants.

May 18, 2001

Cooperative Groups, NCI To Talk About Overlaps

March 14, 1975

HCFA Draft Document Dampens Jubilation Over Clinton Plan To Pay Patient Care Costs.

June 16, 2000

Funding opportunities listed.

September 17, 2004